Literature DB >> 15289513

Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter.

R E Ashcroft1, C Franey.   

Abstract

Evaluation of the potential of a cocaine vaccine requires a detailed understanding of the intended and unintended social consequences of its use. Prospective technology assessment is always difficult, but in the case of treatment and prevention of cocaine addiction we need to understand not only the neuroscience and pharmacology of cocaine addiction, but also social attitudes to drug use and addiction, the social context of drug use, and the factors which make drug use a rational strategy for an addict and make treatment seeking or relapse more or less likely. By considering different scenarios related to differing levels of effectiveness of the vaccine, the authors argue that vaccination will be at best a useful adjunct to existing methods of treatment, rather than a substitute for them.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Substances:

Year:  2004        PMID: 15289513      PMCID: PMC1733918          DOI: 10.1136/jme.2003.005017

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  11 in total

1.  Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment.

Authors:  Tim Rhodes; Larissa Mikhailova; Anya Sarang; Catherine M Lowndes; Andrey Rylkov; Mikhail Khutorskoy; Adrian Renton
Journal:  Soc Sci Med       Date:  2003-07       Impact factor: 4.634

Review 2.  Neuroethics: an agenda for neuroscience and society.

Authors:  Jonathan D Moreno
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

3.  Are over-simplified views of addiction neuroscience providing too simplified ethical considerations?

Authors:  George R Uhl
Journal:  Addiction       Date:  2003-07       Impact factor: 6.526

4.  Addiction, neuroscience and ethics.

Authors:  Wayne Hall; Lucy Carter; Katherine I Morley
Journal:  Addiction       Date:  2003-07       Impact factor: 6.526

5.  The 'brain disease' idea, drug policy and research ethics.

Authors:  Mark Kleiman
Journal:  Addiction       Date:  2003-07       Impact factor: 6.526

6.  Addiction, ethics and scientific freedom.

Authors:  Wayne Hall; Lucy Carter; Katherine I Morley
Journal:  Addiction       Date:  2003-07       Impact factor: 6.526

7.  Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.

Authors:  W Hall; L Carter
Journal:  J Med Ethics       Date:  2004-08       Impact factor: 2.903

8.  Nicotine conjugate vaccine: is there a right to a smoking future?

Authors:  A Hasman; Søren Holm
Journal:  J Med Ethics       Date:  2004-08       Impact factor: 2.903

9.  Cynthia's dilemma: consenting to heroin prescription.

Authors:  Louis C Charland
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

Review 10.  Therapeutic vaccines for substance dependence.

Authors:  Thomas R Kosten; Diane Biegel
Journal:  Expert Rev Vaccines       Date:  2002-10       Impact factor: 5.217

View more
  3 in total

1.  Immune to addiction: the ethical dimensions of vaccines against substance abuse.

Authors:  Michael J Young; Dominic A Sisti; Hila Rimon-Greenspan; Jason L Schwartz; Arthur L Caplan
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

2.  Ethical Implications in Vaccine Pharmacotherapy for Treatment and Prevention of Drug of Abuse Dependence.

Authors:  Anna Carfora; Paola Cassandro; Alessandro Feola; Francesco La Sala; Raffaella Petrella; Renata Borriello
Journal:  J Bioeth Inq       Date:  2018-01-19       Impact factor: 1.352

3.  Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development.

Authors:  Vincent Wartenweiler; Grace Chung; Amy Stewart; Cody Wenthur
Journal:  BMC Med Ethics       Date:  2021-03-25       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.